\-\ Texto\\:\\ \ \(0\)\
\-\ patient\\ demonstrates\\ an\\ 18\\ week\\ sized\\ uterus\\.\ \(0\)\
\-\ patient\\ underwent\\ uterine\\ artery\\ embolization\\ and\\ will\\ follow\\ up\\ in\\ 3\\ months\\ for\\ repeat\\ imaging\\ and\\ reassessment\\ of\\ symptoms\\.\ \(0\)\
\-\ imaging\\ findings\\:\ \(1\)\
\-\ mri\\ demonstrates\\ an\\ 18\\ cm\\ uterus\\ with\\ 3\\ dominant\\ fibroids\\ in\\ the\\ anterior\\ body\\ measuring\\ 4\\.2\\,\\ 3\\.2\\,\\ and\\ 4\\.8\\ cm\\ in\\ diameter\\.\\ \\ no\\ ascites\\,\\ ovarian\\ lesions\\ or\\ adnexal\\ masses\\ were\\ demonstrated\\.\ \(0\)\
\-\ angiographic\\ findings\\ demonstrate\\ a\\ diffusely\\ enlarged\\ uterus\\ with\\ dominant\\ vascularity\\ on\\ the\\ right\\.\\ \\ post\\ embolization\\ angiogram\\ demonstrates\\ no\\ significant\\ uterine\\ flow\\.\ \(0\)\
\-\ uterine\\ artery\\ embolization\\ for\\ uterine\\ fibroids\ \(0\)\
\-\ n\\/a\ \(127\)\
\-\ 48\\ year\\ old\\ female\\ with\\ history\\ of\\ menorrhagia\\ and\\ pelvic\\ pain\\.\ \(1\)\
\-\ uterine\\ artery\\ embolization\\ is\\ a\\ minimally\\ invasive\\ treatment\\ for\\ symptomatic\\ uterine\\ fibroids\\.\\ \\ this\\ method\\ of\\ treatment\\ allows\\ the\\ patient\\ to\\ have\\ a\\ shorter\\ course\\ of\\ recovery\\ when\\ compared\\ to\\ hysterectomy\\.\\ \\ patient\\ was\\ discharged\\ home\\ the\\ following\\ day\\ without\\ complications\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ uterine\\:\\ 0\\.17422655464065634\ \(0\)\
\-\ fibroids\\:\\ 0\\.10894001153227736\ \(0\)\
\-\ embolization\\:\\ 0\\.10541023886132504\ \(0\)\
\-\ uterus\\:\\ 0\\.08002702015598251\ \(0\)\
\-\ dominant\\:\\ 0\\.05776385599619854\ \(0\)\
\-\ artery\\:\\ 0\\.05055357600214965\ \(0\)\
\-\ reassessment\\:\\ 0\\.04920015935660005\ \(0\)\
\-\ 18\\:\\ 0\\.049133416557164473\ \(0\)\
\-\ menorrhagia\\:\\ 0\\.0431320088143871\ \(0\)\
\-\ 4\\.8\\:\\ 0\\.041394497129171925\ \(0\)\
\-\ shorter\\:\\ 0\\.040903715856630725\ \(0\)\
\-\ 3\\.2\\:\\ 0\\.03923938189450552\ \(0\)\
\-\ 4\\.2\\:\\ 0\\.03888132082649045\ \(0\)\
\-\ angiographic\\:\\ 0\\.038218516465185925\ \(0\)\
\-\ hysterectomy\\:\\ 0\\.037616054357863235\ \(0\)\
\-\ demonstrates\\:\\ 0\\.03708518943681827\ \(0\)\
\-\ method\\:\\ 0\\.03522523750000012\ \(0\)\
\-\ allows\\:\\ 0\\.034835565314417775\ \(0\)\
\-\ sized\\:\\ 0\\.03395125145597723\ \(0\)\
\-\ ascites\\:\\ 0\\.032473479592969215\ \(0\)\
\-\ adnexal\\:\\ 0\\.03126605206453244\ \(0\)\
\-\ vascularity\\:\\ 0\\.03126605206453244\ \(0\)\
\-\ recovery\\:\\ 0\\.030838644639780304\ \(0\)\
\-\ cm\\:\\ 0\\.03035703467307266\ \(0\)\
\-\ minimally\\:\\ 0\\.029444175970195212\ \(0\)\
\-\ diffusely\\:\\ 0\\.028580852673087638\ \(0\)\
\-\ invasive\\:\\ 0\\.028435296999453363\ \(0\)\
\-\ 48\\:\\ 0\\.027687347256535513\ \(0\)\
\-\ angiogram\\:\\ 0\\.02737342514465085\ \(0\)\
\-\ home\\:\\ 0\\.02690018697258367\ \(0\)\
\-\ repeat\\:\\ 0\\.02662071442628978\ \(0\)\
\-\ imaging\\:\\ 0\\.026517534098749705\ \(0\)\
\-\ 3\\:\\ 0\\.02650298710869589\ \(0\)\
\-\ discharged\\:\\ 0\\.025944891549772097\ \(0\)\
\-\ ovarian\\:\\ 0\\.02589565328164284\ \(0\)\
\-\ findings\\:\\ 0\\.024090555440926618\ \(0\)\
\-\ compared\\:\\ 0\\.023953784057620348\ \(0\)\
\-\ diameter\\:\\ 0\\.023809023833696513\ \(0\)\
\-\ pelvic\\:\\ 0\\.023226826003743664\ \(0\)\
\-\ treatment\\:\\ 0\\.022908833901998504\ \(0\)\
\-\ patient\\:\\ 0\\.022691176977917563\ \(0\)\
\-\ measuring\\:\\ 0\\.02263149485065394\ \(0\)\
\-\ symptomatic\\:\\ 0\\.022483333938372266\ \(0\)\
\-\ complications\\:\\ 0\\.022424985397430843\ \(0\)\
\-\ course\\:\\ 0\\.021354512870567163\ \(0\)\
\-\ n\\/a\\:\\ 0\\.020498057267278717\ \(0\)\
\-\ underwent\\:\\ 0\\.019418516791246485\ \(0\)\
\-\ enlarged\\:\\ 0\\.01930874881049011\ \(0\)\
\-\ week\\:\\ 0\\.019218645154491575\ \(0\)\
\-\ masses\\:\\ 0\\.01912975098010654\ \(0\)\
\-\ flow\\:\\ 0\\.01870234355535441\ \(0\)\
\-\ body\\:\\ 0\\.018379229885358176\ \(0\)\
\-\ follow\\:\\ 0\\.017981453456598902\ \(0\)\
\-\ day\\:\\ 0\\.01796662138644324\ \(0\)\
\-\ post\\:\\ 0\\.017820099556770157\ \(0\)\
\-\ will\\:\\ 0\\.017705172307146636\ \(0\)\
\-\ demonstrated\\:\\ 0\\.016605430347397136\ \(0\)\
\-\ when\\:\\ 0\\.016207491639841098\ \(0\)\
\-\ following\\:\\ 0\\.016061442098683102\ \(0\)\
\-\ an\\:\\ 0\\.015651190255426887\ \(0\)\
\-\ months\\:\\ 0\\.015456564865497135\ \(0\)\
\-\ up\\:\\ 0\\.015217530801683598\ \(0\)\
\-\ significant\\:\\ 0\\.015217530801683598\ \(0\)\
\-\ lesions\\:\\ 0\\.015149407326781111\ \(0\)\
\-\ anterior\\:\\ 0\\.01457478691233601\ \(0\)\
\-\ for\\:\\ 0\\.014485592357140037\ \(0\)\
\-\ symptoms\\:\\ 0\\.014103691899987676\ \(0\)\
\-\ without\\:\\ 0\\.01332459050568318\ \(0\)\
\-\ demonstrate\\:\\ 0\\.01302286186313272\ \(0\)\
\-\ mri\\:\\ 0\\.013001826853739204\ \(0\)\
\-\ were\\:\\ 0\\.012849578388674975\ \(0\)\
\-\ have\\:\\ 0\\.012254556810364846\ \(0\)\
\-\ female\\:\\ 0\\.011634173983098236\ \(0\)\
\-\ no\\:\\ 0\\.011396611267600026\ \(0\)\
\-\ in\\:\\ 0\\.008372130400137515\ \(0\)\
\-\ a\\:\\ 0\\.007879466261296715\ \(0\)\
\-\ history\\:\\ 0\\.007815990315940949\ \(0\)\
\-\ \\:\\:\\ 0\\.007485263682057384\ \(0\)\
\-\ pain\\:\\ 0\\.00691131236775321\ \(0\)\
\-\ or\\:\\ 0\\.006632600986514619\ \(0\)\
\-\ was\\:\\ 0\\.0065448842530707735\ \(0\)\
\-\ this\\:\\ 0\\.006365147108040616\ \(0\)\
\-\ year\\:\\ 0\\.0063318229753173165\ \(0\)\
\-\ right\\:\\ 0\\.005971070921261037\ \(0\)\
\-\ old\\:\\ 0\\.005794268853392415\ \(0\)\
\-\ to\\:\\ 0\\.005656531237655447\ \(0\)\
\-\ \\,\\:\\ 0\\.005378345672528888\ \(0\)\
\-\ on\\:\\ 0\\.004793980214340583\ \(0\)\
\-\ and\\:\\ 0\\.0047684504829726745\ \(0\)\
\-\ is\\:\\ 0\\.003723779989302819\ \(0\)\
\-\ the\\:\\ 0\\.003662232707380816\ \(0\)\
\-\ of\\:\\ 0\\.00308619339862221\ \(0\)\
\-\ \\.\\:\\ 0\\.002350962655453396\ \(0\)\
\-\ with\\:\\ 0\\.0023245862799315844\ \(0\)\
